Structural and functional heterogeneity of nuclear bodies

Molecular and Cellular Biology

Volumn 19, Issue 6, 1999, Pages 4423-4430

  Bloch, Donald B ^a   Chiche, Jean Daniel ^a   Orth, Donald ^a   De La Monte, Suzanne M ^a   Rosenzweig, Anthony ^a   Bloch, Kenneth D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHLORAMPHENICOL ACETYLTRANSFERASE; GAMMA INTERFERON; NUCLEAR PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL NUCLEUS INCLUSION BODY; CELL STRAIN COS1; GENE TRANSFER; HELA CELL; HEP 2 CELL; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPORTER GENE; TRANSCRIPTION REGULATION;

EID: 0032973688     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.6.4423     Document Type: Article

References (36)

1. Ahn, J.-H., and G. S. Hayward. 1997. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 71:4599-4613.
2. Ahn, M.-J., K. Nason-Burchenal, M. M. Moasser, and E. Dmitrovsky. 1995. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles; RARα or PML. Oncogene 10: 2307-2314.
3. Ascoli, C. A., and G. G. Maul. 1991. Identification of a novel nuclear domain. J. Cell Biol. 112:785-795.
4. Bloch, D. B., S. M. de la Monte, P. Guigaouri, A. Filippov, and K. D. Bloch. 1996. Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem. 46:29198-29204.
5. Borrow, J., A. Goddard, D. Sheer, and E. Solomon. 1990. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577-1580.
6. Brasch, K., and R. L. Ochs. 1992. Nuclear bodies (NBs): a newly "rediscovered" organelle. Exp. Cell Res. 202:211-223.
7. Carvalho, T., J.-S. Seeler, K. Ohman, P. Jordan, U. Petterson, G. Akusjarvi, M. Carmo-Fonseca, and A. Dejean. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131:45-56.
8. Dent, L. D., J. Yewdell, F. Puvion-Dutilleul, M. H. M. Koken, H. de The, and L. M. Staudt. 1996. LySp100-associated nuclear domains (LANDS): description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood 88:1423-1436.
9. de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684.
10. Dong, G., A. Schulick, M. B. De Young, and D. A. Dichek. 1996. Identification of a cis-acting sequence in the human PAI-1 gene that mediates TGF-1 responsiveness in endothelium in vivo. J. Biol. Chem. 271:29969-29977.
11. Doucas, V., A. M. Ishov, A. Romo, H. Juguilon, M. D. Weitzman, R. M. Evans, and G. G. Maul. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:196-207.
12. Dyck, J. A., G. G. Maul, W. H. Miller, J. D. Chen, A. Kakizuka, and R. M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343.
13. Evans, J., A. Reuben, and J. Craft. 1991. PBC 95K, a 95-kilodalton nuclear autoantigen in primary biliary cirrhosis. Arthritis Rheum. 34:731-736.
14. Graham, F. L., and L. Preyec. 1991. Manipulation of adenovirus vectors, p. 109-128. In E. Murray (ed.), Methods in molecular biology: gene transfer and expression protocols, Humana Press, Clifton, N.J.
15. Grotzinger, T., T. Sternsdorf, K. Jensen, and H. Will. 1996. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 238: 554-560.
16. He, D., Z.-M. Mu, X. Le, J.-T. Hsieh, R.-C. Pong, L. W. K. Chung, and K.-S. Chang. 1997. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res. 57:1868-1872.
17. Kakizuka, A., W. H. Miller, K. Umesono, R. P. Warrell, S. R. Frankel, V. V. Murty, E. Dmitrovsky, and R. M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663-674.
18. Kaplan, M. M. 1996. Primary biliary cirrhosis. N. Engl. J. Med. 335:1570-1580.
19. Kim, S.-S., Y.-M. Chen, E. O'Leary, R. Witzgall, M. Vidal, and J. V. Bonventre. 1996. A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc. Natl. Acad. Sci. USA 93:15299-15304.
20. Koken, M. H. M., G. Linares-Cruz, F. Quignon, A. Viron, M. K. Chelbi-Alix, J. Sobczak-Thepot, L. Juhlin, L. Degos, F. Calvo, and H. de The. 1995. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315-1324.
21. Koken, M. H. M., F. Puvion-Dutilleul, M. C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, L. Degos, E. Puvion, and H. de The. 1994. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13:1073-1083.
22. LaMorte, V. J., J. A. Dyck, R. L. Ochs, and R. E. Evans. 1998. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95:4991-4996.
23. Lavau, C., A. Marchio, M. Fagioli, J. Jansen, B. Falini, P. Lebon, F. Grosveld, P. P. Pandolfi, P. G. Pelicci, and A. Dejean. 1995. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11:871-876.
24. Le, X.-F., P. Yang, and K.-S. Chang. 1996. Analysis of growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271:130-135.
25. Le Douarin, B., C. Zechel, J.-M. Garnier, Y. Lutz, L. Tora, B. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14:2020-2033.
26. Longo, L., P. P. Pandolfi, A. Biondi, A. Rombaldi, A. Mencarelli, F. Lo Coco, D. Direrio, L. Pegoraro, G. Avanzi, A. Tabilio, D. Zangrilli, M. Alcalay, E. Donti, F. Grignani, and P. G. Pelicci. 1990. Rearrangements and aberrant expression of the retinoic acid receptor a gene in acute promyelocytic leukemias. J. Exp. Med. 172:1571-1575.
27. Neumann, J. R., C. A. Mornecy, and K. O. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques 5:444-447.
28. Puvion-Dutilleul, F., M. K. Chelbi-Alix, M. Koken, F. Quignon, E. Puvion, and H. de The. 1995. Adenovirus infection induces rearrangement in the intranuclear distribution of the nuclear body-associated PML protein. Exp. Cell Res. 218:9-16.
29. Seeler, J.-S., A. Marchia, D. Sitterlin, C. Transy, and A. Dejean. 1998. Interaction of Sp100 and HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Natl. Acad. Sci. USA 95:7316-7321.
30. Sternsdorf, T., T. Grotzinger, K. Jensen, and H. Will. 1997. Nuclear dots: actors on many stages. Immunoblotting 198:307-331.
31. Sternsdorf, T., K. Jensen, and H. Will. 1997. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/ SUMO-1. J. Cell Biol. 139:1621-1634.
32. Szostecki, C., H. H. Guldner, H. J. Netter, and H. Will. 1990. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145:4338-4347.
33. Szostecki, C., H. H. Guldner, and H. Wills. 1997. Autoantibodies against "nuclear dots" in primary biliary cirrhosis. Semin. Liver Dis. 17:71-77.
34. Wang, Z. G., L. Delva, M. Gaboli, R. Rivi, M. Giorgio, C. Cordon-Cardo, F. Grosveld, and P. P. Pandolfi. 1998. Role of PML in cell growth and the retinoic acid pathway. Science 279:1547-1551.
35. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76: 345-356.
36. Xie, K., E. J. Lambie, and M. Snyder. 1993. Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol. 13:6170-6179.